1 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Nalmefene
Nalmefene
💬
|
Nalmefene
| 1件: 6 6 💬
|
2 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Naltrexone
Naltrexone
💬
|
Naltrexone
| 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
|
3 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Oxycodone
Oxycodone
💬
|
Oxycodone
| 5件: 6 6, 13, 70, 226, 298 💬
|
4 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Loperamide
Loperamide
💬
|
Loperamide
| 2件: 13 13, 97 💬
|
5 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Nalbuphine
Nalbuphine
💬
|
Nalbuphine
| 1件: 85 85 💬
|
6 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Naloxone
Naloxone
💬
|
Naloxone
| 2件: 6 6, 226 💬
|